Background: Anastomotic leaks after low anterior resection for rectal cancer remain the most feared complication. The aim of our study was to investigate whether the use of a transanal tube could reduce the leakage rate after this surgical procedure. Methods: This is a retrospective analysis of a single-institution experience. The study includes 66 patients who underwent low anterior resection for rectal cancer without stoma creation between January 2008 and June 2013. Patients were divided into two groups, i.e. those with a transanal drainage tube (TT; n = 9) and those without tube (NTT; n = 57), and evaluated for clinically evident anastomotic leakage and postoperative complications. Results: The postoperative anastomotic leakage appeared in 5 patients (9%) in the NTT group while no single case was observed within the TT group. Despite the disadvantageous background in the TT group (a transanal stent was used in the most high-risk patients), these patients had no postoperative complications. In the NTT group, 23% had some kind of postoperative complications, and 5% died. The difference between the two groups is not significant. Conclusions: Our study showed that the use of a transanal tube in low anterior resection for rectal cancer could potentially be a simple and effective method of reducing anastomotic leakage. In order to prove our observations, larger prospective randomized studies should be performed.

1.
Ruggiero R, Sparavigna L, Docimo G, et al: Post-operative peritonitis due to anastomotic dehiscence after colonic resection. Multicentric experience, retrospective analysis of risk factors and review of the literature. Ital Chir 2011;82:369-375.
2.
Carlsen E, Schlichting E, Guldvog I, Johnson E, Heald RJ: Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg 1998;85:526-529.
3.
Cong ZJ, Fu CG, Wang HT, Liu LJ, Zhang W, Wang H: Influencing factors of symptomatic anastomotic leakage after anterior resection of the rectum for cancer. World J Surg 2009;33:1292-1297.
4.
Nishigori H, Ito M, Nishizawa Y, Nishizawa Y, Kobayashi A, Sugito M, Saito N: Effectiveness of a transanal tube for the prevention of anastomotic leakage after rectal cancer surgery. World J Surg 2014;38:1843-1851.
5.
Konishi T, Watanabe T, Kishimoto J, Nagawa H: Risk factors for anastomotic leakage after surgery for colorectal cancer: results of prospective surveillance. J Am Coll Surg 2006;202:439-444.
6.
Law WL, Chu KW: Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann Surg 2004;240:260-268.
7.
Matthiessen P, Hallböök O, Andersson M, Rutegård J, Sjödahl R: Risk factors for anastomotic leakage after anterior resection of the rectum. Colorectal Dis 2004;6:462-469.
8.
Machado M, Hallböök O, Goldman S, Nyström PO, Järhult J, Sjödahl R: Defunctioning stoma in low anterior resection with colonic pouch for rectal cancer: a comparison between two hospitals with a different policy. Dis Colon Rectum 2002;45:940-945.
9.
Skrovina M, Soumarova R, Kycina R, et al: Anastomotic leakage after laparoscopic total mesorectal excision for low rectal cancer. Videosurgery Miniinv 2011;6:5-11.
10.
Hut'an M, Lukác I, Poticný V: Prevention of the anastomosis dehiscence following low anterior rectal resections (article in Slovakian). Rozhl Chir 2005;84:501-504.
11.
Fontanili M, Caforio M, Asteria C: Perioperative complications in traditional surgery of the rectum. Minerva Chir 1997;52:217-224.
12.
Rullier E, Laurent C, Garrelon JL, Michel P, Saric J, Parneix M: Risk factors for anastomotic leakage after resection of rectal cancer. Br J Surg 1998;85:355-358.
13.
Pokorny H, Herkner H, Jakesz R, Herbst F: Mortality and complications after stoma closure. Arch Surg 2005;140:956-960.
14.
Koperna T: Cost-effectiveness of defunctioning stomas in low anterior resections for rectal cancer: a call for benchmarking. Arch Surg 2003;138:1334-1338.
15.
Zhao WT, Hu FL, Li YY, Li HJ, Luo WM, Sun F: Use of a transanal drainage tube for prevention of anastomotic leakage and bleeding after anterior resection for rectal cancer. World J Surg 2013;37:227-232.
16.
Xiao L, Zhang WB, Jiang PC, Bu XF, Yan Q, Li H et al.: Can transanal tube placement after anterior resection for rectal carcinoma reduce anastomotic leakage rate? A single-institution prospective randomized study. World J Surg 2011;35:1367-1377.
17.
Amin AI, Ramalingam T, Sexton R, Heald RJ, Leppington-Clarke A, Moran BJ: Comparison of transanal stent with defunctioning stoma in low anterior resection for rectal cancer. Br J Surg 2003;90:581-582.
18.
Pătraşcu T, Doran H, Muşat O: Protective transanal tube in colo-rectal anastomosis (article in Hungarian). Chirurgia (Bucur) 2004;99:75-78.
19.
Vignali A, Fazio VW, Lavery IC, et al: Factors associated with the occurrence of leaks in stapled rectal anastomoses: a review of 1,014 patients. J Am Coll Surg 1997;185:105-113.
20.
Pakkastie TE, Luukkonen PE, Järvinen HJ: Anastomotic leakage after anterior resection of the rectum. Eur J Surg 1994;160:293-297.
21.
David GG, Slavin JP, Willmott S, Corless DJ, Khan AU, Selvasekar CR: Loop ileostomy following anterior resection: is it really temporary? Colorectal Dis 2010;12:428-432.
22.
Lindgren R, Hallböök O, Rutegård J, Sjödahl R, Matthiessen P: What is the risk for a permanent stoma after low anterior resection of the rectum for cancer? A six-year follow-up of a multicenter trial. Dis Colon Rectum 2011;54:41-47.
23.
Bülow S, Bulut O, Christensen IJ, Harling H: Transanal stent in anterior resection does not prevent anastomotic leakage. Colorectal Dis 2006;8:494-496.
24.
Sterk P, Schubert F, Günter S, Klein P: Anastomotic protection with a transanal tube after rectum resection and total mesorectal excision. Zentralbl Chir 2001;126:601-604.
25.
Montemurro S, De Luca R, Caliandro C, et al: Transanal tube NO COIL® after rectal cancer proctectomy. The ‘G. Paolo II' Cancer Centre experience. Tumori 2012;98:607-614.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.